The Prostate

Cover image for Vol. 75 Issue 2

Early View (Online Version of Record published before inclusion in an issue)

Edited By: John T. Isaacs

Impact Factor: 3.566

ISI Journal Citation Reports © Ranking: 2013: 10/75 (Urology & Nephrology); 47/123 (Endocrinology & Metabolism)

Online ISSN: 1097-0045


  1. 1 - 23
  1. Original Articles

    1. Male pattern baldness in relation to prostate cancer risks: An analysis in the VITamins and lifestyle (VITAL) cohort study

      Cindy Ke Zhou, Alyson J. Littman, Paul H. Levine, Heather J. Hoffman, Sean D. Cleary, Emily White and Michael B. Cook

      Article first published online: 9 DEC 2014 | DOI: 10.1002/pros.22927

    2. Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats

      Yasuhito Funahashi, Zhou Wang, Katherine J. O'Malley, Pradeep Tyagi, Donald B. DeFranco, Jeffrey R. Gingrich, Ryosuke Takahashi, Tsuyoshi Majima, Momokazu Gotoh and Naoki Yoshimura

      Article first published online: 28 NOV 2014 | DOI: 10.1002/pros.22924

    3. Prostate cancer cells induce osteoblastic differentiation via semaphorin 3A

      Fuzhou Liu, Weiwei Shen, Hao Qiu, Xu Hu, Chao Zhang and Tongwei Chu

      Article first published online: 24 NOV 2014 | DOI: 10.1002/pros.22923

    4. Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens

      Gregory P. Swanson, Jonathan I. Epstein, Chul S. Ha and Oleksandr N. Kryvenko

      Article first published online: 21 NOV 2014 | DOI: 10.1002/pros.22928

    5. Carbohydrate intake, glycemic index and prostate cancer risk

      Adriana C. Vidal, Christina D. Williams, Emma H. Allott, Lauren E. Howard, Delores J. Grant, Megan McPhail, Katharine N. Sourbeer, Lin Pao Hwa, Paolo Boffetta, Cathrine Hoyo and Stephen J. Freedland

      Article first published online: 21 NOV 2014 | DOI: 10.1002/pros.22929

  2. Original Article

    1. The beta-3 adrenoceptor agonist, mirabegron relaxes isolated prostate from human and rabbit: New therapeutic indication?

      Fabiano B. Calmasini, Tuany Z. Candido, Eduardo C. Alexandre, Carlos A. D'Ancona, Daniel Silva, Marco Antonio de Oliveira, Gilberto De Nucci, Edson Antunes and Fabíola Z. Mónica

      Article first published online: 21 NOV 2014 | DOI: 10.1002/pros.22930

  3. Original Articles

    1. You have full text access to this OnlineOpen article
      Prostate cancer risk prediction based on complete prostate cancer family history

      Frederick Albright, Robert A. Stephenson, Neeraj Agarwal, Craig C. Teerlink, William T. Lowrance, James M. Farnham and Lisa A. Cannon Albright

      Article first published online: 18 NOV 2014 | DOI: 10.1002/pros.22925

    2. Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes

      Lisa Yan, Diane M. Da Silva, Bhavna Verma, Andrew Gray, Heike E. Brand, Joseph G. Skeate, Tania B. Porras, Shreya Kanodia and W. Martin Kast

      Article first published online: 14 NOV 2014 | DOI: 10.1002/pros.22914

    3. Comparative effectiveness of [18F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer

      Jean-Baptiste Pinaquy, Henri De Clermont-Galleran, Gilles Pasticier, Gerald Rigou, Nicolas Alberti, Elif Hindie, Yacoub Mokrane and Philippe Fernandez

      Article first published online: 12 NOV 2014 | DOI: 10.1002/pros.22921

    4. Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer

      Tijl Vermassen, Charles Van Praet, Nicolaas Lumen, Karel Decaestecker, Dieter Vanderschaeghe, Nico Callewaert, Geert Villeirs, Piet Hoebeke, Simon Van Belle, Sylvie Rottey and Joris Delanghe

      Article first published online: 30 OCT 2014 | DOI: 10.1002/pros.22918

    5. 18F-RB390: Innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET)

      Reto Bertolini, Christine Goepfert, Thomas Andrieu, Sara Nichols, Martin A. Walter, Felix J. Frey, J. Andrew McCammon and Brigitte M. Frey

      Article first published online: 30 OCT 2014 | DOI: 10.1002/pros.22919

  4. Review Articles

    1. Beyond immune checkpoint blockade: New approaches to targeting host–tumor interactions in prostate cancer: Report from the 2014 Coffey–Holden prostate cancer Academy meeting

      Andrea K. Miyahira, Haydn T. Kissick, Jennifer L. Bishop, David Y. Takeda, Christopher E. Barbieri, Jonathan W. Simons, Kenneth J. Pienta and Howard R. Soule

      Article first published online: 30 OCT 2014 | DOI: 10.1002/pros.22920

  5. Original Articles

    1. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer

      June Escara-Wilke, Jill M. Keller, Kathleen M. Woods Ignatoski, Jinlu Dai, Gregory Shelley, Atsushi Mizokami, Jian Zhang, Miranda L Yeung, Kam C. Yeung and Evan T. Keller

      Article first published online: 18 OCT 2014 | DOI: 10.1002/pros.22915

    2. Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts

      Vincent A. DiPippo, William C. Olson, Holly M. Nguyen, Lisha G. Brown, Robert L. Vessella and Eva Corey

      Article first published online: 18 OCT 2014 | DOI: 10.1002/pros.22916

  6. Letters to the Editor

    1. You have full text access to this OnlineOpen article
      Irreversible electroporation: Just another form of thermal therapy?

      Martin J. C. van Gemert, Peter G. K. Wagstaff, Daniel M. de Bruin, Ton G. van Leeuwen, Allard C. van der Wal, Michal Heger and Cees W. M. van der Geld

      Article first published online: 18 OCT 2014 | DOI: 10.1002/pros.22913

  7. Original Articles

    1. Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer

      Jose D. Murga, Sameer M. Moorji, Amy Q. Han, Wells W. Magargal, Vincent A. DiPippo and William C. Olson

      Article first published online: 18 OCT 2014 | DOI: 10.1002/pros.22910

    2. Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate

      James R. Lambert, Ramon J. Whitson, Kenneth A. Iczkowski, Francisco G. La Rosa, Maxwell L. Smith, R. Storey Wilson, Elizabeth E. Smith, Kathleen C. Torkko, Hamid H. Gari and M. Scott Lucia

      Article first published online: 18 OCT 2014 | DOI: 10.1002/pros.22911

    3. Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis

      Shanora G. Brown, Ashley E. Knowell, Aisha Hunt, Divya Patel, Sushma Bhosle and Jaideep Chaudhary

      Article first published online: 18 OCT 2014 | DOI: 10.1002/pros.22912

    4. You have full text access to this OnlineOpen article
    5. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?

      Tao Zhao, Banghua Liao, Jin Yao, Jiyan Liu, Rui Huang, Pengfei Shen, Zhufeng Peng, Haojun Gui, Xueqin Chen, Peng Zhang, Yuchun Zhu, Xiang Li, Qiang Wei, Qiao Zhou, Hao Zeng and Ni Chen

      Article first published online: 13 OCT 2014 | DOI: 10.1002/pros.22906


  1. 1 - 23